• News

"Digital Pathology Poised to Take Off With FDA Clearances, AI Applications"

  • 360 DX
  • New York, NY
  • (July 03, 2019)

In June, Laboratory Corporation of America and The Mount Sinai Hospital said that they were working with Philips to establish the Mount Sinai Digital and Artificial Intelligence Enabled Pathology Center of Excellence using the IntelliSite Pathology platform. Under its collaboration with Philips and Mount Sinai to establish the Mount Sinai Digital and Artificial Intelligence Enabled Pathology Center of Excellence, LabCorp will help integrate digital pathology throughout the Mount Sinai system. Additionally, Mount Sinai pathologists will provide expert consultations when needed on samples from LabCorp customers. We have … key opinion leaders of national and international reputations, and we already receive on a routine basis from patients both inside and outside New York, and digital pathology is a tool that will ease that extramural clinical services that we offer the community,” said Carlos Cordon-Cardo, MD, PhD, chairman of the department of pathology, molecular and cell-Based medicine at Mount Sinai Health System and professor of pathology, genetics and genomic sciences, and oncological Sciences at the Icahn School of Medicine at Mount Sinai.   

— Carlos Cordon-Cardo, MD, PhD, Professor, Pathology, Genetics and Genomic Sciences, Oncological Sciences, System Chair, Department of Pathology, Icahn School of Medicine at Mount Sinai

Learn more